Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, works by slowing stomach emptying and signaling fullness to your brain—changes that often produce side effects during the first few weeks of treatment. Most patients experience mild to moderate symptoms that fade within 4 to 8 weeks as their body adapts. Knowing what to expect helps you prepare and maintain your commitment to therapy.

Common Semaglutide Side Effects and Timeline

The majority of people taking semaglutide report nausea as the most frequent side effect, especially during the first two to four weeks of starting therapy or increasing your dose. This nausea typically occurs shortly after injection and may be accompanied by mild stomach discomfort or loss of appetite. Most patients find that symptoms resolve naturally as their digestive system adapts to the medication's mechanism of action.

Vomiting, constipation, and diarrhea are also reported during the adjustment phase, though these occur less frequently than nausea. Fatigue and mild dizziness have been documented in clinical trials, usually appearing during the initial weeks before subsiding. Appetite suppression—while therapeutically beneficial—can feel like an unusual sensation if you're accustomed to normal hunger patterns, but this adaptation is often gradual and manageable.

Why Semaglutide Causes These Gastrointestinal Changes

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar and appetite by slowing how quickly food moves through your stomach. This delayed gastric emptying reduces hunger signals and creates the sensation of fullness, which directly causes nausea and changes in bowel habits as your digestive tract adjusts to a new rhythm. Your body gradually becomes accustomed to this process, which is why side effects typically diminish over time.

The medication also affects the chemoreceptor trigger zone in your brain, the area responsible for detecting and responding to nausea signals. Starting with a low dose and gradually increasing it—a process called titration—allows your gastrointestinal system and nervous system to adapt more gently. This step-wise approach significantly reduces the intensity and duration of side effects compared to starting at a higher dose immediately.

Managing Semaglutide Side Effects Effectively

Eating small, frequent meals with less fat and fiber during the first few weeks can minimize nausea and digestive upset. Staying hydrated, avoiding rapid position changes, and getting adequate rest support your body's adjustment process. Many patients find that ginger, peppermint tea, or over-the-counter anti-nausea medications can provide temporary relief while your system adapts.

If constipation develops, increasing water intake and adding gentle fiber through vegetables and whole grains—rather than supplements, which may worsen nausea—often resolves the issue naturally. For diarrhea, temporarily reducing high-fiber foods and focusing on bland, easily digestible options can help. Communicating with your care provider about symptom severity ensures you receive personalized guidance and can adjust your approach as needed.

When to Contact Your Provider About Side Effects

Most semaglutide side effects are expected and temporary, but severe or persistent vomiting lasting more than a few hours, signs of dehydration, or severe abdominal pain warrant immediate medical attention. Rapid heartbeat, difficulty breathing, or signs of allergic reaction are rare but require emergency care. Your healthcare provider can distinguish between normal adjustment symptoms and complications that require treatment adjustments.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long do Ozempic side effects typically last?

Most common side effects like nausea and mild gastrointestinal discomfort resolve within 4 to 8 weeks as your body adapts to semaglutide. Fatigue and dizziness usually fade within 2 to 4 weeks. Individual timelines vary based on dose, starting dose, and your body's adjustment rate.

Can I prevent nausea when starting semaglutide?

Yes—eating smaller, lower-fat meals; staying well-hydrated; and starting with the lowest dose possible significantly reduce nausea risk. Gradual dose increases over several weeks give your digestive system time to adapt, which is why titration schedules exist. Some patients benefit from ginger supplements or anti-nausea medication during the first 2 to 4 weeks.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) and remains flat across all dose levels—your dose may need to go up, but your price won't. No insurance is required, and the medication is HSA/FSA eligible. Service covers all 50 states.

Is compounded semaglutide as safe as brand-name Ozempic?

PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies, which follow strict FDA quality and sterility standards. While compounded medications are not FDA-approved (like brand-name drugs), they are legally produced and widely prescribed by physicians. Your provider determines the safest option for your individual health profile.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx Precision Peptide Genetic Test analyzes 14 peptide pathways and 150+ genetic insights, including GLP1R and GIPR variants that influence how your body responds to semaglutide. Results help your provider anticipate tolerability and may guide compound selection—such as choosing oral semaglutide or tirzepatide if injection-related side effects are predicted. The test costs $99 as an add-on after your first month of treatment.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves